Is this you? Create Your Porfile
Avatar

John D. Pluenneke

Amgen

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where John D. Pluenneke is active.

Explore More

Publication

Featured researches published by John D. Pluenneke.

Archive | 2001

Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L

Kendall M. Mohler; Dauphine Barone; Jacques J. Peschon; Mary K. Kennedy; John D. Pluenneke

Archive | 2001

Use of il-4r antibodies and compositions thereof

John D. Pluenneke; Richard J. Armitage; Jose Carlos Escobar; Arvia E. Morris

Archive | 2001

Utilisation des antagonistes de l'interleukine-4 et compositions correspondantes

Richard J. Armitage; Jose Carlos Escobar; Arvia E. Morris; John D. Pluenneke

Archive | 2001

Use of interleukin-4 receptor (il-4r) antibodies and compositions thereof

Arvia E. Morris; John D. Pluenneke; Richard J. Armitage; Jose Carlos Escobar

Archive | 2001

CD30 or CD30 antagonist for treatment of autoimmune and inflammatory conditions Kronisch

Kendall M. Mohler; Dauphine Barone; Jacques J. Peschon; Mary K. Kennedy; John D. Pluenneke

Archive | 2001

Antagonists of cd30 or cd30l for use in treating auto-immune and chronic inflammatory conditions

Dauphine Barone; Mary K. Kennedy; Kendall M. Mohler; Jacques J. Peschon; John D. Pluenneke

Archive | 2001

Use of interleukin-4 receptor antibodies and compositions thereof

Arvia E. Morris; John D. Pluenneke; Richard J. Armitage; Jose Carlos Escobar

Archive | 2001

Verwendung von Interleukin-4 Antagonisten und deren Zusammensetzungen

Richard J. Armitage; Jose Carlos Escobar; Arvia E. Morris; John D. Pluenneke

Archive | 2001

Antagonistes de cd30 ou cd30l pour de traitement des troubles inflammatoires auto-immuns et chroniques

Dauphine Barone; Mary K. Kennedy; Kendall M. Mohler; Jacques J. Peschon; John D. Pluenneke

Archive | 2001

Verfahren zur behandlung von autoimmun und kronisch entzündlichen zuständen mittels cd30 oder cd30l antagonisten

Dauphine Barone; Mary K. Kennedy; Kendall M. Mohler; Jacques J. Peschon; John D. Pluenneke

Explore More

Collaboration

Dive into the John D. Pluenneke's collaboration.

Top Co-Authors
Avatar

Jose Carlos Escobar

Amgen

View shared research outputs
Top Co-Authors
Avatar

Richard J. Armitage

Amgen

View shared research outputs
Top Co-Authors
Avatar

Dauphine Barone

Amgen

View shared research outputs
Top Co-Authors
Avatar

Jacques J. Peschon

Amgen

View shared research outputs
Top Co-Authors
Avatar

Arvia E. Morris

Seattle University

View shared research outputs
Top Co-Authors
Avatar

Kendall M. Mohler

University of California

View shared research outputs
Top Co-Authors
Avatar

Mary K. Kennedy

Northwestern University

View shared research outputs
Top Co-Authors
Avatar

Arvia E. Morris

Seattle University

View shared research outputs
Top Co-Authors
Avatar

Kendall M. Mohler

University of California

View shared research outputs
Top Co-Authors
Avatar

Mary K. Kennedy

Northwestern University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge